Stage IV Squamous Cell Carcinoma of the Nasopharynx Completed Phase 1 Trials for 7-Hydroxystaurosporine (DB01933)

IndicationStatusPhase
DBCOND0028783 (Stage IV Squamous Cell Carcinoma of the Nasopharynx)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT000316817-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)Treatment